News Daily News Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI Michael O'Riordan April 22, 2025
News Daily News High-Sensitivity Troponin Tests Might Aid in Primary Prevention Yael L. Maxwell April 16, 2025
News Daily News High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life L.A. McKeown April 14, 2025
News Daily News Weekend Warriors Also See Mortality Benefits With Exercise Michael O'Riordan April 10, 2025
News Daily News FDA Drops REMS Requirement for Antihypertensive Aprocitentan Michael O'Riordan April 09, 2025
News Conference News ACC 2025 RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up Michael O'Riordan April 08, 2025
News Conference News ACC 2025 Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection Michael O'Riordan March 30, 2025
News Conference News EHRA 2025 Uncertainties Remain About Same-Day Discharge After AF Ablation Todd Neale March 30, 2025
News Daily News ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients Michael O'Riordan March 26, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Daily News Cannabis Use Again Tied to Increased CVD Risk in Young People L.A. McKeown March 19, 2025
News Daily News Newer Weight-Loss Drugs Not Cost-effective at Current Prices Michael O'Riordan March 18, 2025
News Daily News Take Heed of Sex Differences in Peripheral Vascular Disease: AHA Michael O'Riordan March 13, 2025
News Daily News SCAD Story Fleshed Out by Clues About Causes, Treatment Risks Yael L. Maxwell March 13, 2025
News Conference News CRT 2025 Need for Rethink of Discharge Medications After LAA Closure? EMERGE L.A. McKeown March 12, 2025
News Daily News Food Insecurity in Adulthood Signals Greater Risk of Later CVD Todd Neale March 12, 2025
News Daily News REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF Michael O'Riordan March 11, 2025